SAN LEANDRO, Calif.–Alpha Innotech Corp. (OTCBB:APNO), a leading provider of gel imaging systems for drug discovery and life science research, announced that Mssrs. Chris van Ingen and Dr. Shahram Hejazi were elected to its Board of Directors during the Company’s most recent annual meeting.

Mr. van Ingen has served as a consultant to the Company since 2008. He retired in 2007 from his position as President of the Bio-Analytical Measurement business of Agilent Technologies, Inc., a position he had held since May 2001. Prior to that, Mr. van Ingen was Vice President of Sales and Marketing of the Chemical Analysis Group at Hewlett Packard from 1996 to April 2001, and held several other senior management positions at Hewlett Packard’s Avondale Division prior to 1996. Mr. van Ingen is a member of the board of directors of Symyx Technologies, Incorporated.

Dr. Shahram Hejazi has been executive-in-residence at BioAdvance, a venture capital organization focused on Life Sciences, Diagnostics and BioPharma, since September 2008. Dr. Hejazi was President, Molecular Imaging Business Unit of Carestream Health, Inc. (formerly Kodak Health Group, a division of Eastman Kodak Company) from 2004 to 2008. From 2001 to 2004, Dr. Hejazi was President and Chief Executive Officer of Zargis Medical Corp., a medical technology company. From 1996 to 2001, Dr. Hejazi served as Head of Strategic Business Development at Siemens Corporate Research, Inc. Dr. Hejazi is an FDA Industry Advisory Panel Member for Molecular and Clinical Genetic Devices, and an Advisory Board Member for Fox Chase Cancer Center, PA. Dr. Hejazi received his Ph.D. in electrical engineering (biophysics group) at State University of New York at Buffalo.

Mr. van Ingen and Dr. Shahram Hejazi fill seats that were vacated by Mssrs. James Chamberlain and Gus Davis.

”Chris and Shahram both bring deep sector experience to Alpha Innotech at a key stage of our growth. I and the rest of our executive team are delighted to have them engaged and contributing to our future success,” said Ron Bissinger, Alpha Innotech’s CEO. “We also owe our gratitude to Jim and Gus, who were instrumental in guiding our Company through the many challenges of the last several years.”

More information on Alpha Innotech can be found at the Company’s website www.alphainnotech.com.

About Alpha Innotech Corp.

With over 10,000 systems sold worldwide, Alpha Innotech is a leading developer, manufacturer and marketer of digital imaging and analysis systems for the life science research and drug discovery markets. Our goal is to combine instruments, reagents and bioinformatics software to offer integrated modular technology platforms for functional genomics, proteomics and cell analysis markets. Our customers include pharmaceutical and biotechnology companies as well as universities, medical centers, government research institutes and agencies worldwide.